Transgenomic, Inc. Reports First Quarter 2009 Results
Frost & Sullivan Awards Precision Biosciences for Technology Innovation and Molecular Design Process in the Genomics Market
Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy
10,000 New Jobs, Investments Increased
Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content. Terms and conditions, including restrictions on redistribution, apply. Copyright © 1996-2009 PR Newswire Association LLC. All Rights Reserved. A United Business Media company.